Brain tumor vaccine links mutation targeting to eight-year survival gains

Дата публикации: 06-07-2026 16:00:09

A novel vaccination strategy against certain malignant brain tumors could fundamentally improve treatment for patients. Researchers from the German Cancer Research Center (DKFZ), Mannheim University Medical Center, Heidelberg University Hospital and numerous partner institutions have published encouraging long-term results from a clinical trial involving a vaccine that activates the immune system against a common genetic mutation in these tumors.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	First-in-human immunotherapy more than doubles progression-free survival in glioblastoma patients	7	8	10-07-2026
2	Researchers uncover 'hidden key' to immunotherapy for intractable brain tumors	2	8	20-07-2026
3	Германия — Охота на мутанта	0	7	09-07-2026
4	Vaccine may ‘intercept’ pancreatic cancer before it starts	0	13.27	16-07-2026
5	حقنة جديدة تبعث الأمل.. علاج واعد يقضي على أورام السرطان	7	8	01-06-2026
6	В ФМБА завершили доклиническое исследование нового противоопухолевого препарата	0	0	04-03-2025
7	The AECC supports a dozen CNIO projects to improve immunotherapy and chemotherapy, advance prevention, and treat early-stage brain metastasis	0	12.32	26-06-2026
8	Precise Sarcoma Therapy: Dresden Research Team Develops Image-Guided Molecular Treatment	5	7	16-07-2026
9	New, improved method to find and isolate the strongest cancer-fighting immune cells	7	8	08-07-2026
10	Precision therapy for metastatic prostate cancer improves survival	2	7	20-08-2024

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 7. Информативность: 8. Источник: medicalxpress.com.